PROVE2: Phase II study of VX950 (telaprevir) in combination with peginterferon alfa2a with or without ribavirin in subjects with chronic hepatitis C, first interim analysis

被引：0
|
作者：
Hezode, Christophe
Ferenci, Peter
Dusheiko, Geoffrey M.
Pol, Stanislas
Goeser, Tobias
Bronowicki, Jean-Pierre
Gharakhanian, Shahin
Devonish, Desiree
Kauffman, Robert
Alam, John
Pawlotsky, Jean-Michel
Zeuzem, Stefan
机构：
[1] Hop Henri Mondor, AP HP, Hepatogastroenterol Serv, F-94010 Creteil, France
[2] Med Univ Vienna, Vienna, Austria
[3] Royal Free Hosp, Ctr Hepatol, London NW3 2QG, England
[4] Necker Cochin Hosp, AP HP, Liver Unit, Paris, France
[5] Univ Cologne, Cologne, Germany
[6] Nancy Univ Hosp Ctr, CHU, Nancy, France
[7] Vertex Pharmaceut Inc, Med Dev Grp, Cambridge, MA USA
[8] Hop Henri Mondor, AP HP, Dept Bacterol & Virol, F-94010 Creteil, France
[9] Saarland Univ Hosp, Internal Med Clin 2, Homburg, Germany
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
80
引用
收藏
页码：268A / 269A
页数：2
相关论文
共 50 条
  • [21] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [22] Interim analysis of the safety and efficacy of peginterferon alfa-2a plus ribavirin in chronic hepatitis C patients unable to tolerate or nonresponsive to treatment with peginterferon alfa-2b plus ribavirin
    Rustgi, VK
    Esposito, S
    Freilich, B
    Lopez-Talavera, JC
    Lentz, E
    Shiffman, ML
    HEPATOLOGY, 2005, 42 (04) : 692A - 692A
  • [23] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Vangeneugden, T.
    Picchio, G.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S22 - S22
  • [24] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [25] TELAPREVIR COMBINATION WITH PEGINTERFERON ALFA-2A/RIBAVIRIN IN HCV/HIV COINFECTED PATIENTS: 24-WEEK TREATMENT INTERIM ANALYSIS
    Sherman, Kenneth E.
    Rockstroh, Juergen K.
    Dieterich, Douglas T.
    Soriano, Vincent
    Girard, Pierre-Marie
    McCallister, Scott
    Adda, Nathalie
    Adiwijaya, Bambang S.
    Mahnke, Lisa
    Sulkowski, Mark S.
    HEPATOLOGY, 2011, 54 : 1431A - 1431A
  • [26] Neopterin and alt as markers of inflammation in chronic hepatitis C patients during administration of the HCVNS3-4a protease inhibitor telaprevir (VX-950) in combination with peginterferon ALFA 2a
    Gelderblom, H. C.
    Zeuzem, S.
    Weegink, C. J.
    Forestier, N.
    McNair, L.
    Purdy, S.
    Jansen, P. L. M.
    Reesink, H. W.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S224 - S225
  • [27] TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA 2B AND RIBAVIRIN THERAPY FOR GENOTYPE 1 CHRONIC HCV PATIENTS: PHASE 3 STUDY IN JAPAN
    Okanoue, Takeshi
    Hayashi, Norio
    Tsubouchi, Hirohito
    Chayama, Kazuaki
    Toyota, Joji
    Kumada, Hiromitsu
    HEPATOLOGY, 2011, 54 : 985A - 986A
  • [28] Phase II study of celgosivir in combination with peginterferon alfa-2b and ribavirin in chronic hepatitis C genotype-1 non-responder patients
    Kaita, Kelly D.
    Yoshida, Eric M.
    Kunimoto, Dennis
    Anderson, Frank
    Sherman, Morris
    Marotta, Paul
    Scully, Linda J.
    Peltekian, Kevork M.
    Enns, Robert A.
    Diaz-Mitoma, Francisco
    Lee, Sam S.
    Worobetz, Lawrence
    Pankovich, Jim
    Petersen, Annkatrin
    GASTROENTEROLOGY, 2007, 132 (04) : A740 - A740
  • [29] Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: A phase II study
    Gramenzi, Annagiulia
    Cursaro, Carmela
    Margotti, Marzia
    Balsano, Clara
    Spaziani, Alessandra
    Anticoli, Simona
    Loggi, Elisabetta
    Salerno, Maddalena
    Galli, Silvia
    Furlini, Giuliano
    Bernardi, Mauro
    Andreone, Pietro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (47) : 5946 - 5952
  • [30] Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
    Missiha, Sharif
    Heathcote, Jenny
    Arenovich, Tamara
    Khan, Kamran
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (10): : 2181 - 2188
12345